nodes	percent_of_prediction	percent_of_DWPC	metapath
Fosphenytoin—Sinus bradycardia—Hydrochlorothiazide—nephrolithiasis	0.0487	0.0487	CcSEcCtD
Fosphenytoin—Encephalopathy—Hydrochlorothiazide—nephrolithiasis	0.0372	0.0372	CcSEcCtD
Fosphenytoin—Coordination abnormal—Hydrochlorothiazide—nephrolithiasis	0.0243	0.0243	CcSEcCtD
Fosphenytoin—Hyperkalaemia—Hydrochlorothiazide—nephrolithiasis	0.0235	0.0235	CcSEcCtD
Fosphenytoin—Ecchymosis—Hydrochlorothiazide—nephrolithiasis	0.0216	0.0216	CcSEcCtD
Fosphenytoin—Urine output increased—Hydrochlorothiazide—nephrolithiasis	0.0216	0.0216	CcSEcCtD
Fosphenytoin—Polyuria—Hydrochlorothiazide—nephrolithiasis	0.0197	0.0197	CcSEcCtD
Fosphenytoin—Injury—Hydrochlorothiazide—nephrolithiasis	0.0189	0.0189	CcSEcCtD
Fosphenytoin—Gastrointestinal haemorrhage—Hydrochlorothiazide—nephrolithiasis	0.0173	0.0173	CcSEcCtD
Fosphenytoin—Migraine—Hydrochlorothiazide—nephrolithiasis	0.0171	0.0171	CcSEcCtD
Fosphenytoin—Affect lability—Hydrochlorothiazide—nephrolithiasis	0.0171	0.0171	CcSEcCtD
Fosphenytoin—Face oedema—Hydrochlorothiazide—nephrolithiasis	0.0167	0.0167	CcSEcCtD
Fosphenytoin—Mood swings—Hydrochlorothiazide—nephrolithiasis	0.0164	0.0164	CcSEcCtD
Fosphenytoin—Ataxia—Hydrochlorothiazide—nephrolithiasis	0.0163	0.0163	CcSEcCtD
Fosphenytoin—Liver function test abnormal—Hydrochlorothiazide—nephrolithiasis	0.016	0.016	CcSEcCtD
Fosphenytoin—Orthostatic hypotension—Hydrochlorothiazide—nephrolithiasis	0.0158	0.0158	CcSEcCtD
Fosphenytoin—Hypokalaemia—Hydrochlorothiazide—nephrolithiasis	0.0158	0.0158	CcSEcCtD
Fosphenytoin—Gastritis—Hydrochlorothiazide—nephrolithiasis	0.0153	0.0153	CcSEcCtD
Fosphenytoin—Muscular weakness—Hydrochlorothiazide—nephrolithiasis	0.0153	0.0153	CcSEcCtD
Fosphenytoin—Influenza—Hydrochlorothiazide—nephrolithiasis	0.015	0.015	CcSEcCtD
Fosphenytoin—Dysphagia—Hydrochlorothiazide—nephrolithiasis	0.015	0.015	CcSEcCtD
Fosphenytoin—Dysuria—Hydrochlorothiazide—nephrolithiasis	0.014	0.014	CcSEcCtD
Fosphenytoin—Photosensitivity reaction—Hydrochlorothiazide—nephrolithiasis	0.0137	0.0137	CcSEcCtD
Fosphenytoin—Hyperglycaemia—Hydrochlorothiazide—nephrolithiasis	0.0135	0.0135	CcSEcCtD
Fosphenytoin—Pneumonia—Hydrochlorothiazide—nephrolithiasis	0.0134	0.0134	CcSEcCtD
Fosphenytoin—Renal failure—Hydrochlorothiazide—nephrolithiasis	0.0131	0.0131	CcSEcCtD
Fosphenytoin—Conjunctivitis—Hydrochlorothiazide—nephrolithiasis	0.013	0.013	CcSEcCtD
Fosphenytoin—Sweating—Hydrochlorothiazide—nephrolithiasis	0.0128	0.0128	CcSEcCtD
Fosphenytoin—Epistaxis—Hydrochlorothiazide—nephrolithiasis	0.0126	0.0126	CcSEcCtD
Fosphenytoin—Sinusitis—Hydrochlorothiazide—nephrolithiasis	0.0125	0.0125	CcSEcCtD
Fosphenytoin—Bradycardia—Hydrochlorothiazide—nephrolithiasis	0.0122	0.0122	CcSEcCtD
Fosphenytoin—Rhinitis—Hydrochlorothiazide—nephrolithiasis	0.012	0.012	CcSEcCtD
Fosphenytoin—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.0119	0.0119	CcSEcCtD
Fosphenytoin—Pharyngitis—Hydrochlorothiazide—nephrolithiasis	0.0119	0.0119	CcSEcCtD
Fosphenytoin—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.0112	0.0112	CcSEcCtD
Fosphenytoin—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.0103	0.0103	CcSEcCtD
Fosphenytoin—Tension—Hydrochlorothiazide—nephrolithiasis	0.0102	0.0102	CcSEcCtD
Fosphenytoin—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.0102	0.0102	CcSEcCtD
Fosphenytoin—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.0101	0.0101	CcSEcCtD
Fosphenytoin—Back pain—Hydrochlorothiazide—nephrolithiasis	0.0101	0.0101	CcSEcCtD
Fosphenytoin—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.01	0.01	CcSEcCtD
Fosphenytoin—Tremor—Hydrochlorothiazide—nephrolithiasis	0.00978	0.00978	CcSEcCtD
Fosphenytoin—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.00968	0.00968	CcSEcCtD
Fosphenytoin—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.00965	0.00965	CcSEcCtD
Fosphenytoin—Agitation—Hydrochlorothiazide—nephrolithiasis	0.00959	0.00959	CcSEcCtD
Fosphenytoin—Malaise—Hydrochlorothiazide—nephrolithiasis	0.00941	0.00941	CcSEcCtD
Fosphenytoin—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.00938	0.00938	CcSEcCtD
Fosphenytoin—Syncope—Hydrochlorothiazide—nephrolithiasis	0.00936	0.00936	CcSEcCtD
Fosphenytoin—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.00934	0.00934	CcSEcCtD
Fosphenytoin—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.00922	0.00922	CcSEcCtD
Fosphenytoin—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.00917	0.00917	CcSEcCtD
Fosphenytoin—Cough—Hydrochlorothiazide—nephrolithiasis	0.00911	0.00911	CcSEcCtD
Fosphenytoin—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.00889	0.00889	CcSEcCtD
Fosphenytoin—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.00889	0.00889	CcSEcCtD
Fosphenytoin—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00878	0.00878	CcSEcCtD
Fosphenytoin—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.00869	0.00869	CcSEcCtD
Fosphenytoin—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.00859	0.00859	CcSEcCtD
Fosphenytoin—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.00852	0.00852	CcSEcCtD
Fosphenytoin—Shock—Hydrochlorothiazide—nephrolithiasis	0.00838	0.00838	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.00834	0.00834	CcSEcCtD
Fosphenytoin—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00831	0.00831	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00823	0.00823	CcSEcCtD
Fosphenytoin—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.00812	0.00812	CcSEcCtD
Fosphenytoin—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.00796	0.00796	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00776	0.00776	CcSEcCtD
Fosphenytoin—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.0077	0.0077	CcSEcCtD
Fosphenytoin—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00765	0.00765	CcSEcCtD
Fosphenytoin—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00759	0.00759	CcSEcCtD
Fosphenytoin—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.00757	0.00757	CcSEcCtD
Fosphenytoin—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.0075	0.0075	CcSEcCtD
Fosphenytoin—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.0074	0.0074	CcSEcCtD
Fosphenytoin—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00728	0.00728	CcSEcCtD
Fosphenytoin—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00702	0.00702	CcSEcCtD
Fosphenytoin—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00677	0.00677	CcSEcCtD
Fosphenytoin—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00673	0.00673	CcSEcCtD
Fosphenytoin—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00611	0.00611	CcSEcCtD
Fosphenytoin—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00603	0.00603	CcSEcCtD
Fosphenytoin—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00583	0.00583	CcSEcCtD
Fosphenytoin—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00563	0.00563	CcSEcCtD
Fosphenytoin—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00542	0.00542	CcSEcCtD
Fosphenytoin—Rash—Hydrochlorothiazide—nephrolithiasis	0.00537	0.00537	CcSEcCtD
Fosphenytoin—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00537	0.00537	CcSEcCtD
Fosphenytoin—Headache—Hydrochlorothiazide—nephrolithiasis	0.00534	0.00534	CcSEcCtD
Fosphenytoin—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00506	0.00506	CcSEcCtD
